Factors Associated with Lymph Node Metastasis in Radically Resected Rectal Carcinoids: A Systematic Review and Meta-analysis

Journal of Gastrointestinal Surgery

Volumn 17, Issue 9, 2013, Pages 1689-1697

  Zhou, Xin ^a   Xie, Haiting ^a   Xie, Lingduo ^a   Li, Jing ^b   Fu, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Lymph node metastasis; Neuroendocrine tumors; Rectal

Indexed keywords

ARTICLE; CARCINOID; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; PATHOLOGY; RECTUM; RECTUM TUMOR; RISK; RISK FACTOR; STATISTICAL MODEL; TUMOR INVASION;

CARCINOID TUMOR; HUMANS; LYMPHATIC METASTASIS; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; ODDS RATIO; RECTAL NEOPLASMS; RECTUM; RISK FACTORS;

EID: 84883259650     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2249-7     Document Type: Article

References (24)

1. Shields C J, Tiret E, Winter D C. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg, 2010, 252(5): 750-755.
2. Tsikitis V L, Wertheim B C, Guerrero M A. Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis. J Cancer, 2012, 3: 292-302.
3. Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol, 2010, 45(2): 234-243.
4. Caplin M, Sundin A, Nillson O, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology, 2012, 95(2): 88-97.
5. Anthony L B, Strosberg J R, Klimstra D S, et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (NETS): well-differentiated NETS of the distal colon and rectum. Pancreas, 2010, 39(6): 767-774.
6. Ramage J K, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut, 2012, 61(1): 6-32.
7. National Comprehensive Cancer Network (NCCN). NCCN practice guidelines for neuroendocrine tumors [EB/OL]. [2011-07-25] http://www. nccn. org/professionals/physician_gls/pdf/neuroendocrine. pdf.
8. Kasuga A, Chino A, Uragami N, et al. Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution. J Gastroenterol Hepatol, 2012, 27(12): 1801-1807.
9. Kim B N, Sohn D K, Hong C W, et al. Atypical endoscopic features can be associated with metastasis in rectal carcinoid tumors. Surg Endosc, 2008, 22(9): 1992-1996.
10. Shimizu T, Tanaka S, Haruma K, et al. Growth characteristics of rectal carcinoid tumor. Oncology, 2000, 59(3): 229-237.
11. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ, 2005, 330(7491): 565.
12. Konishi T, Watanabe T, Kishimoto J, et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut, 2007, 56(6): 863-868.
13. Tsukamoto S, Fujita S, Yamaguchi T, et al. Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors. Int J Colorectal Dis, 2008, 23(11): 1109-1113.
14. Fujimoto Y, Oya M, Kuroyanagi H, et al. Lymph-node metastases in rectal carcinoids. Langenbecks Arch Surg, 2010, 395(2): 139-142.
15. Lee J B. Clinical characteristics of colorectal carcinoid tumors. Journal of the Korean Society of Coloproctology, 2011, 27(1): 17-20.
16. Yamagishi D, Matsubara N, Noda M, et al. Clinicopathological characteristics of rectal carcinoid patients undergoing surgical resection. Oncology Letters, 2012, 4(5): 910-914.
17. Bosman FT, Carneim F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC. 2010.
18. Glasgow S C, Bleier J I, Burgart L J, et al. Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg, 2012, 16(5): 1019-1028.
19. Bipat S, Glas A S, Slors F J, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology, 2004, 232(3): 773-783.
20. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol, 2012, 19(7): 2212-2223.
21. Modlin I M, Oberg K, Chung D C, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 2008, 9(1): 61-72.
22. Ishii N, Horiki N, Itoh T, et al. Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors. Surg Endosc, 2010, 24(6): 1413-1419.
23. Shim K N, Yang S K, Myung S J, et al. Atypical endoscopic features of rectal carcinoids. Endoscopy, 2004, 36(4): 313-316.
24. Hotta K, Shimoda T, Nakanishi Y, et al. Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids. Pathol Int, 2006, 56(10): 591-596.